The prevalent expression of ST2 by mast cells, group 2 innate lymphoid cells (ILC2s), eosinophils and regulatory T cells (Tregs) allows us to understand how these cells represent the major target of IL-33, alarmin, with a key role in modulating immune cell function in many conditions such as asthma and lung diseases [16,35]. Here, IL33 is linked to lung disorder.